ライフサイエンスコーパス: chimeric protein

1 filing after inducing signalling through our chimeric protein.

2 i and examined the function of the resulting chimeric protein.

3 r, and provide approaches for targeting this chimeric protein.

4 latively weak costimulatory delivered by the chimeric protein.

5 led-coil motifs in the NH(2) terminus of the chimeric protein.

6 when part of it was fused with LBP to form a chimeric protein.

7 eer human red blood cells that express these chimeric proteins.

8 ttempted to generate ectopic eyes with these chimeric proteins.

9 tem, rapamycin is used to heterodimerize two chimeric proteins.

10 d-type RARalpha/RXRalpha or other X-RARalpha chimeric proteins.

11 phrinB2 and EphB4 and did not respond to the chimeric proteins.

12 v, and nef to encode a series of novel HIV-1 chimeric proteins.

13 by the identity of the N-terminal arm in the chimeric proteins.

14 human Src tyrosine kinase to create inactive chimeric proteins.

15 The chimeric proteins act on both reporter and endogenous mR

16 The chimeric proteins activate or repress the targeted mRNAs

17 The chimeric protein also enables cytokine-independent growt

18 Antibodies to this chimeric protein also inhibited unrelated strains of the

19 The mutant chimeric proteins also inhibited proliferation of IFNalp

20 Henipavirus G chimeric protein analysis implicated residue 507 in the

21 Chimeric protein and deletion analyses indicate that two

22 Analysis of an Msh2-Msh6/Msh3 chimeric protein and mutant Msh2-Msh3 complexes showed t

23 the high-affinity binding of VCAM-1/CD106 Fc chimeric protein and promoted VCAM-1-dependent arrest to

24 part, for the higher affinity of the native chimeric protein and the lower affinity of the denatured

25 In this study, using a variety of chimeric proteins and deletion mutants, we define the fe

26 ation were investigated by preparing various chimeric proteins and mutants, using CD8 as a reporter m

27 in vitro Ub binding assays using domain swap chimeric proteins and mutated domains in isolation as we

28 we have constructed a collection of C92/P98 chimeric proteins and tested their abilities, both in th

29 derstand the biochemical properties of these chimeric proteins and to establish a system to study the

30 metal ions modulate assembly kinetics of the chimeric proteins, and the extent of modulation is highl

31 y targeting CSP to synaptic vesicles using a chimeric protein approach.

32 The chimeric proteins are constitutively active, stimulate o

33 Such chimeric proteins are easy to design, express, purify an

34 Here, using these chimeric proteins as epitope suppliers, we compared with

35 The structures of the chimeric proteins assembled into VLPs were verified immu

36 -124 of PrP, Chi3 Tg mice, which express the chimeric protein at a very low level, start developing a

37 Abrogation of Axl activation by soluble Axl chimeric protein (Axl-Fc) or small interfering RNA (siRN

38 ficacy, we designed PvRMC-CSP, a recombinant chimeric protein based on the P. vivax CSP (PvCSP).

39 While several chimeric proteins bearing residues of the M-Vpu transmem

40 subfamily members to Klotho family proteins, chimeric proteins between FGF19 subfamily members or chi

41 Using mutants of paxillin and chimeric proteins between HIC-5 and paxillin, we demonst

42 proteins between FGF19 subfamily members or chimeric proteins between Klotho family members were con

43 ivity of OATP1B3, we constructed a series of chimeric proteins between OATP1B3 and 1B1, expressed the

44 s that did not interact with S(3)-RNase, and chimeric proteins between Pi SLF(1) and Pi SLF(2) to add

45 cific regions, and used truncated Pi SLF(2), chimeric proteins between Pi SLF(2) and one of the Pi SL

46 n heat-induced desensitization, we generated chimeric proteins between TRPV1 and TRPV3, a heat-gated

47 The VEGF-angiopoietin-1 (VA1) chimeric protein bound to both VEGF receptor-2 and Tie2

48 into a bacterial collagen-like protein, this chimeric protein bound to integrin.

49 re we developed a soluble NUDT9H model using chimeric proteins built from complementary polypeptide f

50 ally homologous when expressed as individual chimeric proteins but not when expressed in the context

51 ch allostery can evolve, we have generated a chimeric protein by joining the catalytic domain of an u

52 lar and structural domains so that the final chimeric protein can be utilized to create novel bioacti

53 The resulting chimeric proteins can adopt the [PSI+] prion state in ye

54 This simple but powerful approach, employing chimeric proteins, can reinvigorate studies of 14-3-3/ph

55 ace, and its successful use in the design of chimeric proteins capable of targeting genomic regions o

56 ssion, indicating the strong toxicity of the chimeric protein Chi3.

57 Alefacept is a chimeric protein combining CD58 immunoglobulin-like doma

58 The PIPSL gene encodes a chimeric protein combining the lipid kinase domain of PI

59 cture-function relationships by constructing chimeric proteins combining sequences from CerS2, which

60 It is now evident that DSPP is a chimeric protein composed of 3 parts: dentin sialoprotei

61 A chimeric protein composed of Inv3 sequence at the N term

62 This translocation generates a chimeric protein composed of N-terminal sequences of Inh

63 In this study we used a chimeric protein composed of the 675-residue receptor-bi

64 A chimeric protein composed of the septin Cdc10 and the C-

65 A chimeric protein composed of the surface domain of EnvJ

66 re we demonstrate that FIST15, a recombinant chimeric protein composed of the T-cell-stimulatory cyto

67 Chimeric proteins composed of domains from the two attac

68 We employed chimeric proteins composed of exogenous BH3 domains inse

69 Chimeric proteins composed of HIV Gag (p24) fused to the

70 Using acceptor photobleaching FRET and chimeric proteins composed of MyoD, Id1, E12, E47, E12(N

71 50 partner genes and result in production of chimeric proteins composed of the ALL1 N terminus and th

72 ts leading to GDP release, we have created a chimeric protein comprised of Escherichia coli NFeoB and

73 A contact site A (csA)-SibA chimeric protein comprising only the transmembrane and c

74 We engineered a chimeric protein consisting of GATA4 and the cell-penetr

75 A chimeric protein consisting of the Shroom targeting doma

76 ns of the rod has been addressed by making a chimeric protein consisting of the subfragment 2 (S2) re

77 BGAF is a chimeric protein consisting of two distinct domains: the

78 85beta differ in their N-terminal sequences, chimeric proteins consisting of amino or carboxy-termina

79 steps, we performed an unbiased screen using chimeric proteins consisting of CD4 fused to the muscle

80 Zinc-finger nucleases are chimeric proteins consisting of engineered zinc-finger D

81 Recombinant chimeric proteins consisting of segments of hLf and bovi

82 the branching and cyclobutanation reactions, chimeric proteins constructed from farnesyl diphosphate

83 Through a series of chimeric protein constructions tested for their activity

84 mation reactions are promiscuous in that the chimeric protein containing 14 repeats can readily cross

85 ocumented Pex15p traffic from the ER using a chimeric protein containing a C-terminal glycosylation a

86 A typical MocR/GabR-type regulator is a chimeric protein containing a short N-terminal helix-tur

87 However, expression of a chimeric protein containing only the intracellular phosp

88 AtCGL160, as well as a chimeric protein containing the amino-terminal part of A

89 A chimeric protein containing the beta-subunit of SSO0536

90 teins of Newcastle disease virus (NDV) and a chimeric protein containing the cytoplasmic and transmem

91 verexpressing in vivo a transgene encoding a chimeric protein containing the cytoplasmic domain of GP

92 could be transferred to PRMT1 by creating a chimeric protein containing the N terminus of PRMT8 fuse

93 An E1A-E6 chimeric protein containing the Ser/Thr domain of the E6

94 and undetectable at the cell surface, (ii) a chimeric protein containing the TM of ABCG1 and the cyto

95 Leu-rich repeat extensins (LRXs) are chimeric proteins containing an N-terminal Leu-rich repe

96 noic acid, was decreased in cells expressing chimeric proteins containing at least one ABCD2 moiety.

97 In this regard, we have constructed chimeric proteins containing one or two copies of the cy

98 Like chimeric proteins containing only a single NR2A or NR2B

99 The results demonstrated that chimeric proteins containing the N-lobe or the N1.1 subd

100 teractions, the oligomeric state of purified chimeric proteins containing the Staphylococcal nuclease

101 r basis of transport inhibition, a series of chimeric proteins containing transmembrane and cytosolic

102 Chimeric proteins, containing B-finger sequences from sp

103 2-OB(Stn1) chimeras indicates that whether a chimeric protein contains the Rpa2 or Stn1 version of th

104 induced nuclear export, the human TCF4/POP-1 chimeric protein continues to function as a repressor fo

105 iption of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transc

106 neutralized only by homologous antisera, the chimeric proteins could be neutralized by both BTV-1 and

107 In conclusion, FH-Fc chimeric proteins could serve as adjunctive treatments a

108 Evaluation of the soluble chimeric proteins demonstrated that the meprin A5 antige

109 The analysis of chimeric proteins demonstrated that the N-terminal half

110 Chimeric proteins derived from B. subtilis AbrB and the

111 Recombinant immunotoxins (RITs) are chimeric proteins designed to treat cancer.

112 l basis for receptor selectivity by studying chimeric proteins developed by interchanging loops betwe

113 The chimeric proteins differing in their membrane-targeting

114 Chimeric proteins driven by TAT of HIV have been exploit

115 lecules were covalently fused, the resulting chimeric protein efficiently promoted proliferation.

116 This chimeric protein elicits protective immunity, mediated b

117 We found that the chimeric protein EspA-FliCi filaments were biologically

118 ter transfer function can be maintained in a chimeric protein even when over 40% of the sequence is f

119 ine whose oncogenic potential is driven by a chimeric protein EWS-ATF1 (Ewing's sarcoma protein-activ

120 reatment reduced the levels of each of these chimeric proteins except for one containing mutations in

121 These chimeric proteins exhibit a shift in affinities to refle

122 Mice whose red blood cells carry the chimeric proteins exhibit resistance to 10,000 times the

123 The chimeric protein exhibited decreased cell-surface expres

124 An IE62 TAD-ICP4 chimeric protein exhibited trans-activation ability (10.

125 g chemical cross-linking, we showed that the chimeric protein exists predominantly as a tetramer, med

126 munosorbent assay, the resulting recombinant chimeric proteins expressed epitopes from all three vari

127 al deficiency due to the effects of abnormal chimeric protein expression.

128 line proliferation and growth on LTR2-FABP7 chimeric protein expression.

129 core proteins, NP and M, and containing two chimeric proteins, F/F and H/G, composed of respiratory

130 -derived cell line (HEK 293-C3) to express a chimeric protein (F9CH) comprising the Gla domain of fac

131 We use a chimeric protein, FNoTNc, to investigate the molecular b

132 rehensive series of IL-36 agonist/antagonist chimeric proteins for which we measured binding to the I

133 In vitro, these chimeric proteins form amyloid fibers, with more repeats

134 The chimeric proteins form circular octamers, whereas the wi

135 Chimeric proteins formed between the Drosophila P-elemen

136 In this study, we found that a chimeric protein, formed by fusing vaccinia virus protei

137 and betac were expressed in Phoenix cells as chimeric proteins fused to enhanced cyan or yellow fluor

138 This unusual chimeric protein fuses a 70-amino acid N-terminal sequen

139 er of chromosomal translocations that create chimeric proteins, fusing the N terminus of MLL to sever

140 Chimeric proteins generated by fusing the carboxy termin

141 We have catalyzed the four reactions with chimeric proteins generated by replacing segments of a c

142 Chimeric proteins generated from the two phosphatases sh

143 e.g., from nucleases or integrases, to form chimeric proteins, genomes could be manipulated or modif

144 These chimeric proteins had similar effects on normal bone.

145 We show that the chimeric protein has mixed agonistic/antagonist properti

146 ic leukemia, but the function of the encoded chimeric protein has not yet been characterized in detai

147 d C termini of NMDA receptor subunits, these chimeric proteins have been used as a model for studying

148 hannesburg/1/66 HEF full-length protein or a chimeric protein HEF-Ecto, which consists of the HEF ect

149 yt1Aa to Ls's BinA yielding a broad-spectrum chimeric protein highly mosquitocidal to important vecto

150 Moreover, priming with the chimeric protein improved the magnitude and polyfunction

151 omains and expressed each independently as a chimeric protein in a heterologous expression system.

152 Expression of a FANCD2-Ub chimeric protein in RAD18-depleted cells enhances REV1 a

153 o overcome this bottleneck, we constructed a chimeric protein in the cyanobacterium Synechococcus elo

154 yelocytic leukemia (PML) to produce PAX5-PML chimeric protein in two patients with B-cell acute lymph

155 RNA targets bound by the chimeric protein in vivo are covalently marked with urid

156 However, a chimeric protein in which the core kinase domain of PIP5

157 he TCR constant regions and/or creation of a chimeric protein in which the human constant regions wer

158 We found that a chimeric protein in which the mispair-binding domain (MB

159 A chimeric protein in which the ScSec2-GEF domain is repla

160 This was confirmed by use of a chimeric protein in which the SH4 domain of Vac8 was swa

161 xy)-2-propylamine (ATB-BMPA) labeling of the chimeric proteins in low density microsome fractions iso

162 e examined the cleavage-secretion of ACE-CD4 chimeric proteins in mammalian cells and Pichia pastoris

163 hus potential for the production of abnormal chimeric proteins in the brains of translocation carrier

164 vely active anaplastic lymphoma kinase (ALK) chimeric proteins in the pathogenesis of anaplastic larg

165 Investigation of the chimeric proteins in vitro reveals that repeat-expansion

166 Using chimeric proteins in which CD4 is fused to the large int

167 Previous studies of GagZip chimeric proteins in which NC was replaced with a hetero

168 We have now analyzed assembly by chimeric proteins in which nucleocapsid of human immunod

169 By assaying chimeric proteins in which portions of mouse Ro were rep

170 Using this strategy, we designed chimeric proteins in which the activation of the IFNalph

171 Characterization of chimeric proteins in which the AR and C-tail from HPV11

172 f on each protein, we constructed a panel of chimeric proteins in which the extracellular and transme

173 Comparison of chimeric proteins in which the globular head of NDV HN i

174 Using chimeric proteins in which the N- and C-terminal domains

175 In contrast, we show that chimeric proteins in which the neck region of DNGR-1 is

176 ever, several studies have demonstrated that chimeric proteins in which the nucleocapsid domain of Ga

177 ed in Cep164-depleted cells by expression of chimeric proteins in which TTBK2 is fused to the C-termi

178 foreign domain, we found that the resulting chimeric protein, in a concentration-dependent manner, t

179 ytosis and post-endocytic sorting of EGFR, a chimeric protein, in which the K63 linkage-specific deub

180 wo immunological properties: 1) it encodes a chimeric protein including peptides that may be targets

181 Chimeric proteins, including bispecific antibodies, are

182 Chimeric proteins incorporating motifs of cell-penetrati

183 We found that the chimeric protein increased the proliferation of human mo

184 rane targeting and surface expression of the chimeric protein, indicating that the BST-2 GPI anchor s

185 protein, led to nuclear accumulation of this chimeric protein, indicating that this sequence was suff

186 cting signals to direct incorporation of the chimeric protein into the virion.

187 This unique chimeric protein is composed of a 7-transmembrane domain

188 and Western blot analyses confirmed that the chimeric protein is expressed in tumor tissue, and a cel

189 the wild-type and chimeric MLL alleles, the chimeric protein is more stable.

190 ular basis for the oncogenic activity of MLL chimeric proteins is incompletely understood, it seems t

191 n to create fusion genes and their resulting chimeric proteins is supported, including inter-chromoso

192 res delivery to the PVC of either Kex2p or a chimeric protein (K-V), in which the Vps10p cytosolic ta

193 -expressing lymphoid cells stimulated with a chimeric protein linking IL-2 to the ectodomain of TGF-b

194 the LacI/GalR homologues, we have created a chimeric protein (LLhP), which comprises the LacI DNA-bi

195 s replaced with the ORF7b TMD, the resulting chimeric protein localized to the Golgi complex.

196 ried out with single islet cells adherent to chimeric proteins made of functional E-, N-, or P-cadher

197 We previously determined that these chimeric proteins maintain the [PSI+] yeast prion phenot

198 Remarkably, all chimeric proteins maintained prion characteristics.

199 APOBEC3G/APOBEC3B chimeric proteins mapped a primary subcellular localizat

200 ionality of ABCD1/ABCD2 dimers by expressing chimeric proteins mimicking homo- or heterodimers.

201 PiSLF-like protein), and expressed GFP-fused chimeric proteins, named b-2-b and 2-b-2, in S(2) S(3) t

202 We previously reported that a chimeric protein (Nart) that joins the ligand-binding, t

203 A chimeric protein (Nox2/4) consisting of the Nox2 transme

204 l translocation induces the formation of the chimeric protein nucleophosmin-anaplastic lymphoma kinas

205 Using overexpression of a chimeric protein of Eve1 fused to the Gal4 activation do

206 Using chimeric proteins of GLUT5 and GLUT7, here we identified

207 Using chimeric proteins of human and rat CNT2, we determined t

208 howed no requirement for LTP, we constructed chimeric proteins of the two excitatory neuroligin subty

209 the surface of red blood cells by expressing chimeric proteins of VHHs with Glycophorin A or Kell.

210 We also examined the display of chimeric proteins on the gp64null AcMNPV virion.

211 have been developed to reengineer promising chimeric proteins one at a time through targeted point m

212 to increase the proteomic diversity through chimeric proteins or altered regulation.

213 The chimeric protein PAX3-FOXO1, resulting from a translocat

214 esented here explain the properties of these chimeric proteins previously observed in yeast.

215 AML1-ETO is the chimeric protein product of t(8;21) in acute myeloid leu

216 AML1-ETO is the chimeric protein product of the t(8;21) in acute myeloid

217 determine whether the Nmnat1 portion of the chimeric protein provides axonal and somatic protection

218 s lowering the critical concentration of the chimeric protein required for a nucleation reaction.

219 mycetemcomitans using truncated PhoA and Aae chimeric proteins, respectively.

220 enterocolitica strains expressing a Ysp-CyaA chimeric protein resulted in Ysa T3S system-dependent in

221 a role for TANGO1 and TANGO1-like (TALI), a chimeric protein resulting from fusion of MIA2 and cTAGE

222 NUP98-HOXA9, the chimeric protein resulting from the t(7;11)(p15;p15) chr

223 y of mass spectrometry to identify oncogenic chimeric proteins resulting from chromosomal rearrangeme

224 AML1-ETO and TEL-AML1 are chimeric proteins resulting from the t(8;21)(q22;q22) in

225 Further, the chimeric protein retained Msh6-like properties with resp

226 Whereas the CaNpl3 RG chimeric protein retained nearly wild-type function in S

227 We showed that neither chimeric protein retained the SI function of PiSLF(2), s

228 In the case of the F protein, analysis of chimeric proteins revealed that the signal peptide of th

229 Analysis of new chimeric proteins reveals that like T. thermophilus RNas

230 We propose that these chimeric proteins serve to equip melanocytes with novel

231 espite being transactivation-competent, this chimeric protein shows selectivity in p53 effector funct

232 h the major or minor fimbriae to the TLR4-Fc chimeric protein, signaling through TLR4 for both protei

233 The chimeric proteins, silk-elastin-like protein polymers (S

234 We found that a CD300f/Fc chimeric protein specifically binds to apoptotic/dead sp

235 te that mice expressing a soluble B7-2 Ig Fc chimeric protein spontaneously develop colitis that is d

236 simple procedure for the production of such chimeric proteins, starting from correctly folded protei

237 describe how the use of this newly developed chimeric protein strategy has allowed us to test the fun

238 Experiments with chimeric proteins suggest that the C-terminal DNA-bindin

239 Furthermore, these chimeric proteins supported 60S export even in the prese

240 The two chimeric proteins synergized, so that their co-expressio

241 We have taken advantage of a chimeric protein system to study the oligopeptide repeat

242 , the adapters LAT and SLP-76, visualized as chimeric proteins tagged with yellow fluorescent protein

243 f the quadruple mutant of strain 4243 with a chimeric protein that comprised human fH domains 6 and 7

244 d this idea by creating PAS-DHFR, a designed chimeric protein that connects a light-sensing signaling

245 d(s) mutation results in the production of a chimeric protein that contains the full-length coding se

246 these transcription factors creates a unique chimeric protein that controls a key cell-cycle and -dif

247 h the bacterial hemolysin ClyA resulted in a chimeric protein that elicited strong anti-GFP antibody

248 esponding residues from HCMV US6 generates a chimeric protein that inhibits human TAP and provides fu

249 entation by using IL-15 preassociated with a chimeric protein that is comprised of the extracellular

250 parasitic nematode, Ascaris suum, revealed a chimeric protein that is similar to a Phe-Met-Arg-Phe-am

251 c expression of alphaLNNd, a laminin/nidogen chimeric protein that provides a missing polymerization

252 Recombinant immunotoxins (RITs) are chimeric proteins that are being developed for cancer tr

253 rom Ciona intestinalis, Ci-VSP, we generated chimeric proteins that are voltage-sensitive and display

254 ce of BRD-NUT fusion oncogenes, which encode chimeric proteins that block differentiation and maintai

255 he Mixed Lineage Leukemia (MLL) gene produce chimeric proteins that cause abnormal expression of a su

256 Chimeric proteins that comprise contiguous domains of fH

257 However, analysis of chimeric proteins that contained the chaperone modules o

258 everal other non-NKCC1 homologues results in chimeric proteins that form homodimers but show little o

259 r KCNE3 C-termini with that of KCNE4 created chimeric proteins that strongly inhibited KCNQ1.

260 ve residues (HGEKL) in the ACE region of the chimeric proteins that were essential for their cleavage

261 further show, by using an allele encoding a chimeric protein, that this difference maps primarily to

262 ort that activity of nucleophosmin (NPM)/ALK chimeric protein, the dominant form of ALK expressed in

263 tentiating effect required binding of the gD chimeric protein to HVEM.

264 We construct a chimeric protein to interrogate subunit-specific contrib

265 ansmembrane (TM) and luminal tail causes the chimeric protein to lose SLN-like function.

266 wth was corrected with an inability of these chimeric proteins to form stable PD-localized complexes.

267 We used a series of deletion and chimeric proteins to identify the zinc finger domains th

268 We used hA3G/hA3F chimeric proteins to investigate whether cytidine deamin

269 P6981 induced GFP-B-ZIP chimeric proteins to partially localize to the cytoplasm

270 Here, we used chimeric proteins to test whether DAT and SERT N and C t

271 The chimeric protein was expressed in soluble form with high

272 The chimeric protein was readily incorporated into mitochond

273 lting green fluorescent protein (GFP)-tagged chimeric proteins was examined by fluorescence imaging,

274 ing a beta-lactamase (betaLa) reporter/NiV-M chimeric protein, we produced NiVLPs expressing NiV-G an

275 sed GFP reporter system and a recombinant Fc chimeric protein, we show that human FCRL6, a receptor s

276 yAsf1 C-terminal truncations and yeast-human chimeric proteins, we found that truncations at residue

277 Using a series of chimeric proteins, we identified specificity determinant

278 By analyzing ANO1-ANO6 chimeric proteins, we identify a domain in ANO6 necessar

279 Recombinant SIN viruses encoding nsP2/GFP chimeric protein were capable of growth in tissue cultur

280 ken up by mannose-6-phosphate receptors, all chimeric proteins were additionally endocytosed via mann

281 EphB2-Fc and ephrin-B2-Fc chimeric proteins were applied to adult RGC axons in vit

282 he cytoplasmic tail of PC7 were deleted, and chimeric proteins were constructed consisting of the lum

283 We checked that the chimeric proteins were correctly expressed and targeted

284 The chimeric proteins were found to be functional, as demons

285 ng of the role of gL in EBV-mediated fusion, chimeric proteins were made using rhesus lymphocryptovir

286 ies of monomeric and dimeric ebvIL-10.hIL-10 chimeric proteins were produced and characterized for re

287 wapped; NIH3T3 cells overexpressing the four chimeric proteins were tested for transformation activit

288 The chimeric proteins were variably expressed at the cell su

289 A chimeric protein West Nile virus (WNV) vaccine capable o

290 To achieve this goal we made several chimeric proteins where parts of ACAT2 were replaced by

291 However, chimeric proteins whose sequence showed divergence on th

292 parental genes PIP5K1A and PSMD4, forming a chimeric protein with a distinct cellular localization a

293 and minor fimbriae bound to a human TLR2:Fc chimeric protein with an observed K(d) of 28.9 nM and 61

294 position as the full-length protein or as a chimeric protein with its transmembrane and cytoplasmic

295 A chimeric protein with PylSn fused to the N terminus of t

296 the violet range has allowed for designing a chimeric protein with Renilla luciferase.

297 ve been seen for single transmembrane domain chimeric proteins with appended C termini of NMDA recept

298 de, PhrA, was analyzed in part by generating chimeric proteins with RapC, which targets the DNA-bindi

299 ZFNs are chimeric proteins with significant potential for the tre

300 The analysis of chimeric proteins with various N-terminal segments of hi